Preventing misfolding of the prion protein by trimethylamine N-oxide

被引:66
|
作者
Bennion, BJ
DeMarco, ML
Daggett, V [1 ]
机构
[1] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA
[2] Univ Washington, Biomol Struct & Design Program, Seattle, WA 98195 USA
关键词
D O I
10.1021/bi0486379
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transmissible spongiform encephalopathies are a class of fatal neurodegenerative diseases linked to the prion protein. The prion protein normally exists in a soluble, globular state (PrPC) that appears to participate in copper metabolism in the central nervous system and/or signal transduction. Infection or disease occurs when an alternatively folded form of the prion protein (PrPSc) converts soluble and predominantly alpha-helical PrPC into aggregates rich in beta-structure. The structurally disordered N-terminus adopts beta-structure upon conversion to PrPSc at low pH. Chemical chaperones, such as trimethylamine N-oxide (TMAO), can prevent formation of PrPSc in scrapie-infected mouse neuroblastoma cells [Tatzelt, J., et al. (1996) EMBO J. 15, 6363-6373]. To explore the mechanism of TMAO protection of PrPC at the atomic level, molecular dynamics simulations were performed under conditions normally leading to conversion (low pH) with and without 1 M TMAO. In PrPC simulations at low pH, the helix content drops and the N-terminus is brought into the small native beta-sheet, yielding a PrPSc-like state. Addition of 1 M TMAO leads to a decreased radius of gyration, a greater number of protein-protein hydrogen bonds, and a greater number of tertiary contacts due to the N-terminus forming an Omega-Ioop and packing against the structured core of the protein, not due to an increase in the level of extended structure as with the PrPC to PrPSc simulation. In simulations beginning with the "PrPSc-like" structure (derived from PrPC simulated at low pH in pure water) in 1 M TMAO, similar structural reorganization at the N-terminus occurred, disrupting the extended sheet. The mechanism of protection by TMAO appears to be exclusionary in nature, consistent with previous theoretical and experimental studies. The TMAO-induced N-terminal conformational change prevents residues that are important in the conversion of PrPC to PrPSc from assuming extended sheet structure at low pH.
引用
收藏
页码:12955 / 12963
页数:9
相关论文
共 50 条
  • [41] Metabolic retroconversion of trimethylamine N-oxide and the gut microbiota
    Hoyles, Lesley
    Jimenez-Pranteda, Maria L.
    Chilloux, Julien
    Brial, Francois
    Myridakis, Antonis
    Aranias, Thomas
    Magnan, Christophe
    Gibson, Glenn R.
    Sanderson, Jeremy D.
    Nicholson, Jeremy K.
    Gauguier, Dominique
    McCartney, Anne L.
    Dumas, Marc-Emmanuel
    MICROBIOME, 2018, 6 : 73
  • [42] Evaluation of trimethylamine n-oxide levels in pleural effusion
    Aydin, Siyami
    Cakmak, Muharrem
    Gursu, Mehmet Ferit
    Kaymaz, Tugce
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2023, 14 (02): : 125 - 129
  • [43] Trimethylamine N-oxide and prognosis in acute heart failure
    Suzuki, Toru
    Heaney, Liam M.
    Bhandari, Sanjay S.
    Jones, Donald J. L.
    Ng, Leong L.
    HEART, 2016, 102 (11) : 841 - 848
  • [44] Enzymatically Produced Trimethylamine N-Oxide: Conserving It or Eliminating It
    Catucci, Gianluca
    Querio, Giulia
    Sadeghi, Sheila J.
    Gilardi, Gianfranco
    Levi, Renzo
    CATALYSTS, 2019, 9 (12)
  • [45] Trimethylamine N-Oxide, the Microbiome, and Heart and Kidney Disease
    Zeisel, Steven H.
    Warrier, Manya
    ANNUAL REVIEW OF NUTRITION, VOL 37, 2017, 37 : 157 - 181
  • [46] TRANSITION METAL ION COMPLEXES OF TRIMETHYLAMINE N-OXIDE
    DRAGO, RS
    DONOGHUE, JT
    HERLOCKE.DW
    INORGANIC CHEMISTRY, 1965, 4 (06) : 836 - &
  • [47] Trimethylamine N-Oxide and Risk of Cardiovascular Disease and Mortality
    Kanitsoraphan C.
    Rattanawong P.
    Charoensri S.
    Senthong V.
    Current Nutrition Reports, 2018, 7 (4) : 207 - 213
  • [48] Trimethylamine N-Oxide (TMAO), Diet and Cardiovascular Disease
    Minu S. Thomas
    Maria Luz Fernandez
    Current Atherosclerosis Reports, 2021, 23
  • [49] Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients
    Shafi, Tariq
    Powe, Neil R.
    Meyer, Timothy W.
    Hwang, Seungyoung
    Hai, Xin
    Melamed, Michal L.
    Banerjee, Tanushree
    Coresh, Josef
    Hostetter, Thomas H.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 28 (01): : 321 - 331
  • [50] Gut microbiota in atherosclerosis: focus on trimethylamine N-oxide
    Zhu, Yingqian
    Li, Qingqing
    Jiang, Hua
    APMIS, 2020, 128 (05) : 353 - 366